| Dr Nathan Daniel Bodin, MD | |
|
200 Bowman Dr Ste E140, Voorhees, NJ 08043-9631 | |
| (856) 983-4263 | |
| Not Available |
| Full Name | Dr Nathan Daniel Bodin |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 200 Bowman Dr Ste E140, Voorhees, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881855955 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).
Reducing fears that exercise or activity will make symptoms worse is one of the most important factors determining the success of cognitive behaviour therapy (CBT) or graded exercise therapy (GET) in reducing fatigue and improving physical function in people with chronic fatigue syndrome (CFS), according to new analysis of data from the PACE trial, reported in The Lancet Psychiatry journal.
For years Blanca Ramirez, like many Americans, started each new year with a resolution to lose weight. But no more. "I lost 55 pounds this year and the weight is rolling off and will stay off," said the 42 year-old, married, mother of three. Ramirez underwent bariatric surgery at Loyola Center for Metabolic Surgery & Bariatric Care in August and has lost 55 pounds in four months.
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
Physicians' fears of being sued for malpractice are out of proportion to their actual risk of being sued, according to a recent study by a University of Iowa researcher and colleagues.
› Verified 9 days ago
| Entity Name | Advocare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770538696 PECOS PAC ID: 3678562188 Enrollment ID: O20040510001217 |
News Archive
Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).
Reducing fears that exercise or activity will make symptoms worse is one of the most important factors determining the success of cognitive behaviour therapy (CBT) or graded exercise therapy (GET) in reducing fatigue and improving physical function in people with chronic fatigue syndrome (CFS), according to new analysis of data from the PACE trial, reported in The Lancet Psychiatry journal.
For years Blanca Ramirez, like many Americans, started each new year with a resolution to lose weight. But no more. "I lost 55 pounds this year and the weight is rolling off and will stay off," said the 42 year-old, married, mother of three. Ramirez underwent bariatric surgery at Loyola Center for Metabolic Surgery & Bariatric Care in August and has lost 55 pounds in four months.
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
Physicians' fears of being sued for malpractice are out of proportion to their actual risk of being sued, according to a recent study by a University of Iowa researcher and colleagues.
› Verified 9 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).
Reducing fears that exercise or activity will make symptoms worse is one of the most important factors determining the success of cognitive behaviour therapy (CBT) or graded exercise therapy (GET) in reducing fatigue and improving physical function in people with chronic fatigue syndrome (CFS), according to new analysis of data from the PACE trial, reported in The Lancet Psychiatry journal.
For years Blanca Ramirez, like many Americans, started each new year with a resolution to lose weight. But no more. "I lost 55 pounds this year and the weight is rolling off and will stay off," said the 42 year-old, married, mother of three. Ramirez underwent bariatric surgery at Loyola Center for Metabolic Surgery & Bariatric Care in August and has lost 55 pounds in four months.
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
Physicians' fears of being sued for malpractice are out of proportion to their actual risk of being sued, according to a recent study by a University of Iowa researcher and colleagues.
› Verified 9 days ago
| Entity Name | Salem Physician Practices Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245705128 PECOS PAC ID: 3476892050 Enrollment ID: O20190226000892 |
News Archive
Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).
Reducing fears that exercise or activity will make symptoms worse is one of the most important factors determining the success of cognitive behaviour therapy (CBT) or graded exercise therapy (GET) in reducing fatigue and improving physical function in people with chronic fatigue syndrome (CFS), according to new analysis of data from the PACE trial, reported in The Lancet Psychiatry journal.
For years Blanca Ramirez, like many Americans, started each new year with a resolution to lose weight. But no more. "I lost 55 pounds this year and the weight is rolling off and will stay off," said the 42 year-old, married, mother of three. Ramirez underwent bariatric surgery at Loyola Center for Metabolic Surgery & Bariatric Care in August and has lost 55 pounds in four months.
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
Physicians' fears of being sued for malpractice are out of proportion to their actual risk of being sued, according to a recent study by a University of Iowa researcher and colleagues.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nathan Daniel Bodin, MD 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Dr Nathan Daniel Bodin, MD 200 Bowman Dr Ste E140, Voorhees, NJ 08043-9631 Ph: (856) 983-4263 |
News Archive
Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).
Reducing fears that exercise or activity will make symptoms worse is one of the most important factors determining the success of cognitive behaviour therapy (CBT) or graded exercise therapy (GET) in reducing fatigue and improving physical function in people with chronic fatigue syndrome (CFS), according to new analysis of data from the PACE trial, reported in The Lancet Psychiatry journal.
For years Blanca Ramirez, like many Americans, started each new year with a resolution to lose weight. But no more. "I lost 55 pounds this year and the weight is rolling off and will stay off," said the 42 year-old, married, mother of three. Ramirez underwent bariatric surgery at Loyola Center for Metabolic Surgery & Bariatric Care in August and has lost 55 pounds in four months.
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
Physicians' fears of being sued for malpractice are out of proportion to their actual risk of being sued, according to a recent study by a University of Iowa researcher and colleagues.
› Verified 9 days ago
Gary Neil Goldstein, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 Somerdale Rd, Suite 215, Voorhees, NJ 08043 Phone: 856-795-8884 Fax: 856-795-7870 | |
Merrick Wetzler, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 502 Centennial Blvd, Suite 6, Voorhees, NJ 08043 Phone: 856-424-8866 Fax: 856-424-5731 | |
Dr. Jeremy Jackson Reid, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Bowman Dr, Suite E-100, Voorhees, NJ 08043 Phone: 609-267-9400 | |
Jeffrey Daniels, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 502 Centennial Blvd, Suite 6, Voorhees, NJ 08043 Phone: 856-424-8866 Fax: 856-424-5731 | |
Dr. Jennifer J Winell, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1012 Laurel Oak Rd, Suite #1, Voorhees, NJ 08043 Phone: 856-435-1300 Fax: 856-435-0091 | |
Rajesh K. Jain, MD, MPH Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Bowman Dr, Suite E-100, Voorhees, NJ 08043 Phone: 609-267-9400 | |
Thomas J O'dowd, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 502 Centennial Blvd, Suite 6, Voorhees, NJ 08043 Phone: 856-424-8866 Fax: 856-424-5731 |